SCD and metabolic dysfunction-associated steatotic liver disease: PPARγ protein expression is significantly downregulated in NAFLD, and PPARγ transgene liver-knockout mice show a similar decrease in the expression levels of lipogenic genes such as fatty acid synthase (FAS) and SCD-1 [162, 163].